SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027701
Filing Date
2013-05-10
Accepted
2013-05-10 10:10:20
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v342893_10q.htm 10-Q 275015
2 EXHIBIT 31.1 v342893_ex31-1.htm EX-31.1 10744
3 EXHIBIT 31.2 v342893_ex31-2.htm EX-31.2 10707
4 EXHIBIT 32.1 v342893_ex32-1.htm EX-32.1 4576
5 EXHIBIT 32.2 v342893_ex32-2.htm EX-32.2 4763
  Complete submission text file 0001144204-13-027701.txt   2600531

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prph-20130331.xml EX-101.INS 220590
7 XBRL TAXONOMY EXTENSION SCHEMA prph-20130331.xsd EX-101.SCH 36907
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prph-20130331_cal.xml EX-101.CAL 24651
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prph-20130331_def.xml EX-101.DEF 178253
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prph-20130331_lab.xml EX-101.LAB 311459
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prph-20130331_pre.xml EX-101.PRE 212476
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 13831506
SIC: 2834 Pharmaceutical Preparations